Regeneron Pharmaceuticals (REGN) Invested Capital (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Invested Capital came in at $31.4 billion in Q1 2026, up 6.93% year-on-year from $29.4 billion in Q1 2025, and down 1.73% quarter-over-quarter from $32.0 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Invested Capital for 18 years, with the latest figure at $31.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 6.93% year-over-year to $31.4 billion; the trailing twelve-month figure through Mar 2026 stood at $31.4 billion (up 6.93% YoY), and the FY2025 full-year result was $32.0 billion, up 2.04% from the prior year.
- Invested Capital for Q1 2026 stood at $31.4 billion, down from $32.0 billion in the prior quarter.
- The five-year high for Invested Capital was $32.0 billion in Q4 2025, with the low at $20.7 billion in Q1 2022.
- Average Invested Capital over 5 years is $26.9 billion, with a median of $27.0 billion recorded in 2024.
- Year-over-year, Invested Capital soared 62.42% in 2022 and grew 2.04% in 2025.
- Tracing REGN's Invested Capital over 5 years: stood at $23.4 billion in 2022, then rose by 14.14% to $26.7 billion in 2023, then advanced by 17.31% to $31.3 billion in 2024, then rose by 2.04% to $32.0 billion in 2025, then slipped by 1.73% to $31.4 billion in 2026.
- The last three Invested Capital figures came in at $31.4 billion (Q1 2026), $32.0 billion (Q4 2025), and $31.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.42 Bn |
| Dec 31, 2025 | 31.98 Bn |
| Sep 30, 2025 | 30.96 Bn |
| Jun 30, 2025 | 29.94 Bn |
| Mar 31, 2025 | 29.39 Bn |
| Dec 31, 2024 | 31.34 Bn |
| Sep 30, 2024 | 29.33 Bn |
| Jun 30, 2024 | 28.21 Bn |
| Mar 31, 2024 | 26.99 Bn |
| Dec 31, 2023 | 26.71 Bn |
| Sep 30, 2023 | 24.90 Bn |
| Jun 30, 2023 | 24.02 Bn |
| Mar 31, 2023 | 23.50 Bn |
| Dec 31, 2022 | 23.40 Bn |
| Sep 30, 2022 | 22.68 Bn |
| Jun 30, 2022 | 21.41 Bn |
| Mar 31, 2022 | 20.65 Bn |
| Dec 31, 2021 | 20.01 Bn |
| Sep 30, 2021 | 19.24 Bn |
| Jun 30, 2021 | 16.37 Bn |
| Mar 31, 2021 | 12.72 Bn |
| Dec 31, 2020 | 12.26 Bn |
| Sep 30, 2020 | 10.13 Bn |
| Jun 30, 2020 | 10.56 Bn |
| Mar 31, 2020 | 12.13 Bn |
| Dec 31, 2019 | 11.80 Bn |
| Sep 30, 2019 | 10.50 Bn |
| Jun 30, 2019 | 9.76 Bn |
| Mar 31, 2019 | 9.44 Bn |
| Dec 31, 2018 | 8.76 Bn |
| Sep 30, 2018 | 7.87 Bn |
| Jun 30, 2018 | 7.19 Bn |
| Mar 31, 2018 | 6.57 Bn |
| Dec 31, 2017 | 6.14 Bn |
| Sep 30, 2017 | 6.05 Bn |
| Jun 30, 2017 | 5.52 Bn |
| Mar 31, 2017 | 5.59 Bn |
| Dec 31, 2016 | 4.45 Bn |
| Sep 30, 2016 | 4.49 Bn |
| Jun 30, 2016 | 4.08 Bn |
| Mar 31, 2016 | 3.77 Bn |
| Dec 31, 2015 | 3.65 Bn |
| Sep 30, 2015 | 3.30 Bn |
| Jun 30, 2015 | 3.34 Bn |
| Mar 31, 2015 | 2.97 Bn |
| Dec 31, 2014 | 2.55 Bn |
| Sep 30, 2014 | 2.55 Bn |
| Jun 30, 2014 | 2.37 Bn |
| Mar 31, 2014 | 2.21 Bn |
| Dec 31, 2013 | 1.96 Bn |
| Sep 30, 2013 | 1.69 Bn |
| Jun 30, 2013 | 1.49 Bn |
| Mar 31, 2013 | 1.41 Bn |
| Dec 31, 2012 | 1.26 Bn |
| Sep 30, 2012 | 806.02 Mn |
| Jun 30, 2012 | 594.66 Mn |
| Mar 31, 2012 | -30.79 Mn |
| Dec 31, 2011 | 485.73 Mn |
| Sep 30, 2011 | 428.25 Mn |
| Jun 30, 2011 | 478.03 Mn |
| Mar 31, 2011 | 518.09 Mn |
| Dec 31, 2010 | 527.82 Mn |
| Sep 30, 2010 | 348.06 Mn |
| Jun 30, 2010 | 371.22 Mn |
| Mar 31, 2010 | 386.27 Mn |
| Dec 31, 2009 | 396.76 Mn |
| Sep 30, 2009 | 422.44 Mn |
| Jun 30, 2009 | 410.51 Mn |